Browsing Tag
Bharat Biotech
38 posts
Covaxin phase-3 trial concluded successfully at Aligarh Muslim University
The phase-3 trial for Covaxin was done in collaboration with the Indian Council of Medical Research (ICMR) and BBIL.
WHO suspends UN supply of Bharat Biotech’s Covaxin for COVID-19
WHO suspends supply of Bharat Biotech's Covaxin
Covaxin booster dose trial shows ‘long-term safety’: Bharat Biotech
It added that the neutralising antibodies against homologous and heterologous SARS-CoV-2 variants increased 19 to 265-fold after a third vaccination.
Paracetamol not recommended after getting Covaxin jab: Bharat Biotech
"Paracetamol was recommended along with certain other Covid-19 vaccines and is not recommended for Covaxin," it added.
Only Covaxin to be administered to children aged 15-18 yrs
The vaccine option against COVID-19 for children in the age group of 15-18 years, who will be inoculated from January 3, would be Covaxin only, according to new guidelines issued by the Union health ministry on Monday.
Covaxin gets DCGI nod for emergency use for children aged 12-18
This makes Covaxin the second vaccine cleared for use for children in India. Earlier, Zydus Cadila’s three-dose DNA vaccine was allowed to be used on adults and children over the age of 12.
Opened Covaxin vial can be stored for 28 days, says Bharat Biotech
The Central Drugs Standard Control Organisation (CDSCO) last month approved the extension of Covaxin's shelf life up to 12 months from the date of manufacture.
Bharat Biotech to donate 2 lakh doses of Covaxin to Vietnam
Hyderabad, Dec 16 : Bharat Biotech announced on Thursday that it will donate two lakh doses of its…
Developing Covaxin was an enormous challenge: Bharat Biotech
Bengaluru, Nov 19 : Bharat Biotech Director, V. Krishna Mohan, has said developing the Covaxin in “just 10…
Six months after second dose ideal time for booster: Bharat Biotech CMD
On bringing a vaccine for children, Ella said Bharat Biotech was the only company in the world to have done clinical trials among those between 2 and 18 years of age.
WHO body seeks more clarification to decide on Covaxin EUL
The WHO's Technical Advisory Group in a meeting on Tuesday agreed upon to conduct the final risk assessment after receiving additional data from manufacturer.
Covaxin may get WHO approval by month-end, says NITI Aayog
New Delhi, Sep 16 : India’s indigenously-developed Covid vaccine Covaxin may soon receive Emergency Use Listing by the…
Bharat Biotech’s Rotavac 5D receives WHO prequalification
Bharat Biotech developed the first generation, rotavirus vaccine, Rotavac under a public-private partnership with the Department of Biotechnology, and 16 other international partners, making it the largest ever social innovation project for public health.
Bharat Biotech: Working for full US FDA approval of Covaxin
"Therefore, for BLA, data from an additional clinical trial will be required to support the marketing application submission for COVAXIN This process will extend our timelines," it added.
US FDA denies emergency use approval for Covaxin
New Delhi, June 12: The US FDA (United States Food and Drug administration) has denied approval for emergency…
With no EUA, Covaxin’s launch in US may be delayed
In February, Ocugen and Bharat Biotech had entered into a definitive agreement to co-develop, supply, and commercialise Covacin for the US market.
US FDA rejects emergency use authorization for Bharat Biotech’s Covaxin jab
FDA has asked Ocugen, the US partner of Bharat Bio, to launch an additional trial so that it can file for for a full approval
Bharat Biotech’s Covaxin recommended by expert Panel for Phase II/III Trials on 2-18 year-Olds
Earlier the proposal was deliberated in the SEC meeting dated February 24 and the firm was asked to submit a revised clinical trial protocol.
Bharat Biotech cuts Covaxin’s price for states from Rs 600 to Rs 400
HYDERABAD: A day after Serum Institute of India (SII)’s CEO Adar Poonawalla announced a Rs 100 per dose…
Bharat Biotech’s Covaxin to be sold at Rs 600/dose to states, Rs 1,200 to private hospitals
Bharat Biotech further announced that it will also export Covaxin and the export price of the vaccine would be between $15-$20, i.e., between Rs 1,100 to Rs 1,500 per dose, approximately.
Covaxin neutralises double mutant strain: ICMR
"ICMR study shows Covaxin neutralises against multiple variants of SARS-CoV-2.”
COVID-19 in Hyderabad: 54% population developed antibodies against coronavirus, states latest sero survey
Naturally, those who had Covid-19 positive cases in their own households, showed the maximum seropositivity of 78 per cent.
Coronavirus Vaccination: CoWIN opens for self-registration
New Delhi, March 1 : The phase 3 of Covid vaccination started on Monday and the Co-WIN portal…
Modi receives his 1st Covid vaccine dose at AIIMS
PM Modi was administered Bharat BioTech's COVAXIN vaccine shot by Sister P. Niveda, from Puducherry, according to a report by news agency ANI.
Expert panel recommends Phase 1 trial of nasal Covid-19 vaccine
According to the firm, an intranasal vaccine stimulates a broad immune response at the site of infection, in the nasal mucosa, which is essential for blocking both infection and transmission of Covid-19.
Bharat Biotech to pay compensation if Covaxin causes side-effects
The vaccine maker said in phase 1 and phase 2 clinical trials, Covaxin has demonstrated the ability to produce antidotes against COVID- 19
Experts question the emergency use authorization given to Bharat Biotech and AstraZeneca
With these questions and recommendations by these experts, we hope that the Indian government takes an informed decision and give quick approvals or Emergency Use Authorization to other vaccine candidates as well.
Bharat Biotech’s Covaxin can be used as backup, says AIIMS Director Dr Randeep Guleria
The DCGI gave approval for the emergency use of two Covid-19 vaccines, one developed by AstraZeneca and Oxford University and the other by Hyderabad-based Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).
Approval to Covaxin premature, could be dangerous: Shashi Tharoor
Earlier today, Covid-19 vaccines of Serum Institue of India and Bharat Biotech have been granted permission for restricted use in an emergency situation, said DCGI.
Serum Institute, Bharat Biotech’s Covid Vaccines Granted Emergency Use Approval
India's drugs regulator on Sunday approved Oxford University’s Covid-19 vaccine ‘Covishield’ and Bharat Biotech's Covaxin for restricted emergency use.
No vaccine approval yet, drug regulator analysing SII, Bharat Biotech data
On December 9, the Subject Expert Committee had asked the SII and Bharat Biotech to submit more data and information to get approval.
Covaxin can deal with new Covid strains too: Bharat Biotech
The leading vaccine maker is also developing a single-dose nasal vaccine for Covid-19.
Congress’s Anand Sharma Clears “Confusion” Over Tweet On PM Narendra Modi
But the party's critics, as well as many within the organization, saw it as a weak attempt at recovery.
Animal study proved Covid vaccine’s efficacy: Bharat Biotech
Hyderabad, Sep 11 : Vaccine maker Bharat Biotech on Friday announced that the animal trials of its Covid-19…
Bharat Biotech starts human trials of Covid-19 vaccine in PGI Rohtak
Bharat Biotech got the country's drug regulator's approval to start clinical trials of its anti-Corona vaccine Covaxin recently
Bharat Biotech Covid vaccine candidate’s human trials from July
Hyderabad, June 29 : Leading vaccine maker Bharat Biotech on Monday announced that it has successfully developed Covaxin,…
Bharat Biotech: Vaccine development moving positively, next 1 month crucial
New Delhi, June 1 : The development of a vaccine for Covid-19 is moving in a positive direction…
ICMR partners with Bharat Biotech to develop Covid-19 vaccine
According to a statement issued by the ICMR, the team will use the virus strain isolated at ICMR's National Institute of Virology (NIV) in Pune.